focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,748.00
Bid: 1,747.50
Ask: 1,748.50
Change: -27.00 (-1.52%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,746.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end four-day winning run as UK's FTSE drags

Thu, 13th Aug 2020 09:39

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* FTSE 100 leads declines on ex-dividend trading

* Cyclical sectors hand back some of this week's gains

* Thyssenkrupp slides on flagging losses in steel unit

* TUI sinks to 1 bln euro loss in Q3
(Updates to market close)

By Sruthi Shankar and Sagarika Jaisinghani

Aug 13 (Reuters) - European stocks broke a four-day winning
streak on Thursday as ex-dividend trading and a stronger pound
hit the UK's blue-chip companies, while investors sold off banks
and energy stocks that have outperformed this week.

The pan-European STOXX 600 closed 0.6% lower, with
London's FTSE 100 sliding 1.5% as a jump in the pound
hurt exporters on the index, while heavyweights like AstraZeneca
, BP, and GlaxoSmithKline traded without
entitlement to a dividend payout, hitting their shares.

Reversing a recent trend, investors favoured pockets of
markets that have remained resilient in the wake of the
coronavirus crisis such as the technology sector. On Wall
Street, Apple was set to record $2 trillion in market
capitalisation.

That left some of the cyclical sectors that are more exposed
to an economic downturn, such as banks, oil & gas
, miners and automakers, falling between
0.8% and 1.9%.

Geir Lode, head of global equities international at
Federated Hermes, noted that it is difficult to gauge whether a
rally in these cheaper stocks will be sustained.

"It reflects the uncertainty that still pervades the world
as we continue to negotiate our way back to normality as well as
increasing U.S.-China tensions," Lode wrote in a note.

After a U.S. move to ban two popular Chinese apps last week,
investors were nervous about upcoming talks between Beijing and
Washington officials over a trade deal agreed earlier this year.

Meanwhile, U.S. Democrats and Republicans remain deadlocked
after weeks of wrangling over a fifth coronavirus aid bill to
support a struggling economy.

Trillions of dollars in stimulus and a stellar rally in
technology stocks have helped the U.S. S&P 500 index
reach striking distance of a record high. The European blue-chip
index is still about 15% below its February peak, but
the pace of recovery for both from a market crash in March has
been similar.

Weak earnings also dented the mood, with struggling
conglomerate Thyssenkrupp plunging 16.3% after it said
its steel unit would rack up 1 billion euros ($1.2 billion) in
operating losses this year, raising pressure to fix or sell the
division.

TUI, the world's largest tourism company, fell 6.2%
as it sank to a 1.1 billion euro ($1.30 billion) loss in the
third quarter due to the COVID-19 pandemic.

Danish brewer Carlsberg slid 5.8% on a warning
that lockdowns will impact sales in the second half of the year
in its key markets of China and Western Europe.

(Reporting by Sruthi Shankar in Bengaluru; Additional reporting
by Sagarika Jaisinghani; Editing by Arun Koyyur, Bernard Orr and
Giles Elgood)

More News
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.